Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,727,909
-
Share change
-
+4,334,313
-
Total reported value
-
$706,409,522
-
Put/Call ratio
-
75%
-
Price per share
-
$14.80
-
Number of holders
-
168
-
Value change
-
+$61,836,543
-
Number of buys
-
108
-
Number of sells
-
46
Institutional Holders of DIPLOMAT PHARMACY INC - COM (DPLO) as of Q2 2017
As of 30 Jun 2017,
DIPLOMAT PHARMACY INC - COM (DPLO) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,727,909 shares.
The largest 10 holders included
FRONTIER CAPITAL MANAGEMENT CO LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, DAVIS SELECTED ADVISERS, HERMES INVESTMENT MANAGEMENT LTD, RIVERBRIDGE PARTNERS LLC, Cambridge Investment Research Advisors, Inc., STATE STREET CORP, and Clearbridge Investments, LLC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.